Literature DB >> 10515233

Extra neurofilament NF-L subunits rescue motor neuron disease caused by overexpression of the human NF-H gene in mice.

J Meier1, S Couillard-Després, H Jacomy, C Gravel, J P Julien.   

Abstract

Previous studies demonstrated that transgenic mice overexpressing human neurofilament heavy (hNF-H) protein develop a progressive motor neuron disease characterized by the perikaryal accumulations of neurofilaments resembling those found in amyotrophic lateral sclerosis (ALS). To further investigate this neurofilament-induced pathology, we generated transgenic mice expressing, solely or concomitantly, the hNF-H and the human neurofilament light (hNF-L) proteins. We report here that the motor neuron disease caused by excess hNF-H proteins can be rescued by overexpression of hNF-L in a dosage-dependent fashion. In hNF-H transgenic mice, the additional hNF-L led to reduction of perikaryal swellings, relief of axonal transport defect and restoration of axonal radial growth. A gene delivery approach based on recombinant adenoviruses bearing the hNF-L gene also demonstrated the possibility to reduce perikaryal swellings after their formation in adult mice. The finding that extra NF-L can protect against NF-H-mediated pathogenesis is of potential importance for ALS, particularly for cases with NF-H abnormalities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10515233

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  19 in total

1.  Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1.

Authors:  M D Nguyen; R C Larivière; J P Julien
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

Review 2.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

3.  Overexpression of the Cdk5 inhibitory peptide in motor neurons rescue of amyotrophic lateral sclerosis phenotype in a mouse model.

Authors:  Binukumar Bk; Susan Skuntz; Michaela Prochazkova; Sashi Kesavapany; Niranjana D Amin; Varsha Shukla; Philip Grant; Ashok B Kulkarni; Harish C Pant
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

4.  Formation of Mallory body-like inclusions and cell death induced by deregulated expression of keratin 18.

Authors:  Ikuo Nakamichi; Shigetsugu Hatakeyama; Keiichi I Nakayama
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

5.  Formation of intermediate filament protein aggregates with disparate effects in two transgenic mouse models lacking the neurofilament light subunit.

Authors:  J M Beaulieu; H Jacomy; J P Julien
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

Review 6.  Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: a review.

Authors:  Mala V Rao; Ralph A Nixon
Journal:  Neurochem Res       Date:  2003-07       Impact factor: 3.996

Review 7.  TDP-43 in neurodegenerative disorders.

Authors:  Casey Cook; Yong-jie Zhang; Ya-fei Xu; Dennis W Dickson; Leonard Petrucelli
Journal:  Expert Opin Biol Ther       Date:  2008-07       Impact factor: 4.388

8.  A quantitative examination of the role of cargo-exerted forces in axonal transport.

Authors:  Cassie S Mitchell; Robert H Lee
Journal:  J Theor Biol       Date:  2008-12-24       Impact factor: 2.691

9.  Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons.

Authors:  Hong Chen; Kun Qian; Zhongwei Du; Jingyuan Cao; Andrew Petersen; Huisheng Liu; Lisle W Blackbourn; CindyTzu-Ling Huang; Anthony Errigo; Yingnan Yin; Jianfeng Lu; Melvin Ayala; Su-Chun Zhang
Journal:  Cell Stem Cell       Date:  2014-04-03       Impact factor: 24.633

10.  Neurofilamentopathy in neurodegenerative diseases.

Authors:  Quan Liu; Fang Xie; Abdiel Alvarado-Diaz; Mark A Smith; Paula I Moreira; Xiongwei Zhu; George Perry
Journal:  Open Neurol J       Date:  2011-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.